Weride [WRD] vs Salesforce [CRM] Detailed Stock Comparison
Weride
NASDAQ
Loading...
Salesforce
NYSE
Loading...
TLDR: Quick Comparison Summary
Based on 20 vital metrics comparison: Weride wins in 5 metrics, Salesforce wins in 11 metrics, with 0 ties. Salesforce appears stronger overall.
View Metrics Details
Vital Metrics Comparison
| Metric | Weride | Salesforce | Better |
|---|---|---|---|
| P/E Ratio (TTM) | -0.35 | 37.88 | Weride |
| Price-to-Book Ratio | 0.42 | 3.83 | Weride |
| Debt-to-Equity Ratio | 3.18 | 19.81 | Weride |
| PEG Ratio | N/A | 19.95 | N/A |
| EV/EBITDA | -1.24 | 20.20 | Weride |
| Profit Margin (TTM) | 30.66% | 16.08% | Weride |
| Operating Margin (TTM) | -356.87% | 20.12% | Salesforce |
| EBITDA Margin (TTM) | N/A | 20.12% | N/A |
| Return on Equity | -43.04% | 10.31% | Salesforce |
| Return on Assets (TTM) | -23.98% | 5.09% | Salesforce |
| Free Cash Flow (TTM) | $-94.60M | $12.43B | Salesforce |
| Dividend Yield | N/A | 0.62% | N/A |
| 1-Year Return | -45.02% | -6.88% | Salesforce |
| Price-to-Sales Ratio (TTM) | 6.25 | 6.01 | Salesforce |
| Enterprise Value | $398.12M | $226.38B | Salesforce |
| EV/Revenue Ratio | 6.97 | 5.87 | Salesforce |
| Gross Profit Margin (TTM) | 28.07% | 76.96% | Salesforce |
| Revenue per Share (TTM) | $2 | $40 | Salesforce |
| Earnings per Share (Diluted) | $-1.19 | $6.40 | Salesforce |
| Beta (Stock Volatility) | N/A | 1.37 | N/A |
Performance
Key Stats
Valuation
Financials
Short Interest
Dividends
Weride vs Salesforce Stock Performance Analysis
Loading Price Chart...
Performance Comparison
Short-term Returns
| Stock | 1D | 1W | 1M | 3M | 6M | YTD |
|---|---|---|---|---|---|---|
| Weride | 4.62% | -5.70% | -1.41% | -11.31% | -62.74% | -35.87% |
| Salesforce | 0.94% | 5.34% | -6.27% | -12.91% | -20.65% | -25.65% |
Long-term Returns
| Stock | 1Y | 3Y | 5Y | 10Y | 15Y | 20Y |
|---|---|---|---|---|---|---|
| Weride | -45.02% | -45.02% | -45.02% | -45.02% | -45.02% | -45.02% |
| Salesforce | -6.88% | 48.78% | -9.32% | 249.94% | 782.06% | 5,010.81% |
Performance & Financial Health Analysis: Weride vs Salesforce
| Metric | WRD | CRM |
|---|---|---|
| Market Information | ||
| Market Cap | $2.56B | $231.77B |
| Market Cap Category | Mid cap | Mega cap |
| 10 Day Avg. Volume | 6,226,570 | 9,043,110 |
| 90 Day Avg. Volume | 7,698,020 | 6,980,807 |
| Last Close | $9.52 | $248.13 |
| 52 Week Range | $6.03 - $44.00 | $226.48 - $369.00 |
| % from 52W High | -78.36% | -32.76% |
| All-Time High | $44.00 (Feb 17, 2025) | $369.00 (Dec 02, 2024) |
| % from All-Time High | -78.36% | -32.76% |
| Growth Metrics | ||
| Quarterly Revenue Growth | 0.61% | 0.08% |
| Quarterly Earnings Growth | -0.78% | 0.01% |
| Financial Health | ||
| Profit Margin (TTM) | 0.31% | 0.16% |
| Operating Margin (TTM) | -3.57% | 0.20% |
| Return on Equity (TTM) | -0.43% | 0.10% |
| Debt to Equity (MRQ) | 3.18 | 19.81 |
| Cash & Liquidity | ||
| Book Value per Share (MRQ) | $21.47 | $63.33 |
| Cash per Share (MRQ) | $6.45 | $18.21 |
| Operating Cash Flow (TTM) | $-103,434,110 | $13.32B |
| Levered Free Cash Flow (TTM) | $-350,486,428 | $14.43B |
| Dividends | ||
| Last 12-Month Dividend Yield | N/A | 0.62% |
| Last 12-Month Dividend | N/A | $1.62 |
Valuation & Enterprise Metrics Analysis: Weride vs Salesforce
| Metric | WRD | CRM |
|---|---|---|
| Price Ratios | ||
| P/E Ratio (TTM) | -0.35 | 37.88 |
| Forward P/E | -3.67 | 21.78 |
| PEG Ratio | N/A | 19.95 |
| Price to Sales (TTM) | 6.25 | 6.01 |
| Price to Book (MRQ) | 0.42 | 3.83 |
| Market Capitalization | ||
| Market Capitalization | $2.56B | $231.77B |
| Enterprise Value | $398.12M | $226.38B |
| Enterprise Value Metrics | ||
| Enterprise to Revenue | 6.97 | 5.87 |
| Enterprise to EBITDA | -1.24 | 20.20 |
| Risk & Other Metrics | ||
| Beta | N/A | 1.37 |
| Book Value per Share (MRQ) | $21.47 | $63.33 |
Financial Statements Comparison: Weride vs Salesforce
Financial Metrics
Loading Financial Charts...
Revenue
EBITDA
Operating Margin
Free Cash Flow
Long Term Debt
Profit Margin
Current Ratio
Operating Cash Flow
Income Statement (MRQ)
| Metric (MRQ) | WRD | CRM |
|---|---|---|
| Revenue/Sales | $17.71M | $9.83B |
| Cost of Goods Sold | $12.74M | $4.53B |
| Gross Profit | $4.97M | $7.56B |
| Research & Development | $44.41M | $1.46B |
| Operating Income (EBIT) | $-62.96M | $1.98B |
| EBITDA | $-64.84M | $2.92B |
| Pre-Tax Income | $-56.40M | $1.97B |
| Income Tax | $199,974 | $433.00M |
| Net Income (Profit) | $-56.60M | $1.54B |
Balance Sheet & Liquidity Metrics (MRQ)
| Metric (MRQ) | WRD | CRM |
|---|---|---|
| Cash & Equivalents | $534.21M | $10.93B |
| Total Current Assets | $924.00M | $25.87B |
| Total Current Liabilities | $83.73M | $24.20B |
| Long-Term Debt | $9.57M | $10.78B |
| Total Shareholders Equity | $900.13M | $60.67B |
| Retained Earnings | N/A | $17.50B |
| Property, Plant & Equipment | $49.43M | $5.26B |
Cash Flow Statement Comparison (MRQ)
| Metric (MRQ) | WRD | CRM |
|---|---|---|
| Operating Cash Flow | N/A | $6.89B |
| Capital Expenditures | N/A | N/A |
| Free Cash Flow | N/A | $6.30B |
| Debt Repayment | N/A | $-179.00M |
| Common Stock Repurchase | N/A | $-2.63B |
Short Interest & Institutional Ownership Analysis
| Metric | WRD | CRM |
|---|---|---|
| Shares Short | 10.46M | 13.69M |
| Short Ratio | 1.28 | 2.29 |
| Short % of Float | 0.05% | 0.01% |
| Average Daily Volume (10 Day) | 6,226,570 | 9,043,110 |
| Average Daily Volume (90 Day) | 7,698,020 | 6,980,807 |
| Shares Outstanding | 115.06M | 962.00M |
| Float Shares | 566.45M | 930.65M |
| % Held by Insiders | 0.02% | 0.03% |
| % Held by Institutions | 0.08% | 0.83% |
Dividend Analysis & Yield Comparison: Weride vs Salesforce
| Metric | WRD | CRM |
|---|---|---|
| Last 12-Month Dividend | N/A | $1.62 |
| Last 12-Month Dividend Yield | N/A | 0.62% |
| 3-Year Avg Annual Dividend | N/A | $0.67 |
| 3-Year Avg Dividend Yield | N/A | 0.15% |
| 3-Year Total Dividends | N/A | $2.02 |
| Ex-Dividend Date | N/A | Apr 10, 2025 |